ArticleCancer medicine2020

Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.

Mohammed A Alghamdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.